{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T20:51:24Z","timestamp":1697489484100},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Gastroenterol Rep"],"published-print":{"date-parts":[[2005,11]]},"DOI":"10.1007\/s11894-005-0076-z","type":"journal-article","created":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T11:51:38Z","timestamp":1180698698000},"page":"455-461","source":"Crossref","is-referenced-by-count":8,"title":["Celiac disease: Is the atypical really typical? Summary of the recent National Institutes of Health Consensus conference and latest advances"],"prefix":"10.1007","volume":"7","author":[{"given":"Swati","family":"Gadewar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessio","family":"Fasano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"76_CR1","first-page":"687","volume":"36","author":"S Bevan","year":"1999","unstructured":"Bevan S, Popat S, Braegger CP, et al.: Contribution of the MHC region to the familial risk of coeliac disease. J Med Genet 1999, 36:687\u2013690.","journal-title":"J Med Genet"},{"key":"76_CR2","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1080\/00365520310000456","volume":"38","author":"L Hogberg","year":"2003","unstructured":"Hogberg L, Falth-Magnusson K, Grodzinsky E, et al.: Familial prevalence of coeliac disease: a twenty-year follow-up study. Scand J Gastroenterol 2003, 38:61\u201365.","journal-title":"Scand J Gastroenterol"},{"key":"76_CR3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1053\/jcgh.2003.50004","volume":"1","author":"JA Murray","year":"2003","unstructured":"Murray JA, Van Dyke C, Plevak MF, et al.: Trends in the identification and clinical features of celiac disease in a North American community, 1950\u20132001. Clin Gastroenterol Hepatol 2003, 1:19\u201327.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"76_CR4","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1515\/JPEM.2003.16.6.805","volume":"16","author":"L Iughetti","year":"2003","unstructured":"Iughetti L, Bulgarelli S, Forese S, et al.: Endocrine aspects of coeliac disease. J Pediatr Endocrinol Metab 2003, 16:805\u2013818.","journal-title":"J Pediatr Endocrinol Metab"},{"key":"76_CR5","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1590\/S0100-879X2004000100008","volume":"37","author":"MS Queiroz","year":"2004","unstructured":"Queiroz MS, Nery M, Cancado EL, et al.: Prevalence of celiac disease in Brazilian children of short stature. Braz J Med Biol Res 2004, 37:55\u201360.","journal-title":"Braz J Med Biol Res"},{"key":"76_CR6","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/S0022-3476(83)80462-4","volume":"103","author":"E Cacciari","year":"1983","unstructured":"Cacciari E, Salardi S, Lazzari R, et al.: Short stature and celiac disease: a relationship to consider even in patients with no gastrointestinal tract symptoms. J Pediatr 1983, 103:708\u2013711.","journal-title":"J Pediatr"},{"key":"76_CR7","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/(SICI)1520-7560(199907\/08)15:4<254::AID-DMRR47>3.0.CO;2-F","volume":"15","author":"N Locuratolo","year":"1999","unstructured":"Locuratolo N, Pugliese G, Pricci F, et al.: The circulating insulinlike growth factor system in children with coeliac disease: an additional marker for disease activity. Diabetes Metab Res Rev 1999, 15:254\u2013260.","journal-title":"Diabetes Metab Res Rev"},{"key":"76_CR8","first-page":"580","volume":"87","author":"M Peracchi","year":"1992","unstructured":"Peracchi M, Molteni N, Cantalamessa L, et al.: Abnormal growth hormone responsiveness to stimuli in women with active celiac sprue. Am J Gastroenterol 1992, 87:580\u2013583.","journal-title":"Am J Gastroenterol"},{"key":"76_CR9","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1001\/archinte.165.4.393","volume":"165","author":"WF Stenson","year":"2005","unstructured":"Stenson WF, Newberry R, Lorenz R, et al.: Increased prevalence of celiac disease and need for routine screening among patients with osteoporosis. Arch Intern Med 2005, 165:393\u2013399. The prevalence of CD among osteoporotic individuals is much higher than that among non-osteoporotic individuals. This study justifies a recommendation for CD serologic screening of all patients with osteoporosis.","journal-title":"Arch Intern Med"},{"key":"76_CR10","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1093\/ajcn\/67.3.477","volume":"67","author":"S Mora","year":"1998","unstructured":"Mora S, Barera G, Ricotti A, et al.: Reversal of low bone density with a gluten-free diet in children and adolescents with celiac disease. Am J Clin Nutr 1998, 67:477\u2013481. In this study, the bone mineral density was measured in children and adolescents at diagnosis of CD and after approximately 1 year of a GFD, showing improvement of the bone damage.","journal-title":"Am J Clin Nutr"},{"key":"76_CR11","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3109\/00365528209181045","volume":"17","author":"R Ferguson","year":"1982","unstructured":"Ferguson R, Holmes GK, Cooke WT: Coeliac disease, fertility, and pregnancy. Scand J Gastroenterol 1982, 17:65\u201368.","journal-title":"Scand J Gastroenterol"},{"key":"76_CR12","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/S0140-6736(98)05342-2","volume":"352","author":"M Hadjivassiliou","year":"1998","unstructured":"Hadjivassiliou M, Grunewald RA, Chattopadhyay AK, et al.: Clinical, radiological, neurophysiological, and neuropathological characteristics of gluten ataxia. Lancet 1998, 352:1582\u20131585.","journal-title":"Lancet"},{"key":"76_CR13","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1212\/01.WNL.0000063307.84039.C7","volume":"60","author":"RL Chin","year":"2003","unstructured":"Chin RL, Sander HW, Brannagan TH, et al.: Celiac neuropathy. Neurology 2003, 60:1581\u20131585.","journal-title":"Neurology"},{"key":"76_CR14","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1590\/S0004-282X2003000300002","volume":"61","author":"R Pratesi","year":"2003","unstructured":"Pratesi R, Gandolfi L, Martins RC, et al.: Is the prevalence of celiac disease increased among epileptic patients? Arq Neuropsiquiatr 2003, 61:330\u2013334.","journal-title":"Arq Neuropsiquiatr"},{"key":"76_CR15","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s10072-003-0181-4","volume":"24","author":"G Cicarelli","year":"2003","unstructured":"Cicarelli G, Della Rocca G, Amboni M, et al.: Clinical and neurological abnormalities in adult celiac disease. Neurol Sci 2003, 24:311\u2013317.","journal-title":"Neurol Sci"},{"key":"76_CR16","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/00005176-200502000-00015","volume":"40","author":"M Bonamico","year":"2005","unstructured":"Bonamico M, Sabbatella L, Di Tola M, et al.: Antiendomysial antibody detection in biopsy culture allows avoidance of gluten challenge in celiac children. J Pediatr Gastroenterol Nutr 2005, 40:165\u2013169.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"76_CR17","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/j.1572-0241.2005.41069.x","volume":"100","author":"R Petroniene","year":"2005","unstructured":"Petroniene R, Dubcenco E, Baker JP, et al.: Given capsule endoscopy in celiac disease: evaluation of diagnostic accuracy and interobserver agreement. Am J Gastroenterol 2005, 100:685\u2013694.","journal-title":"Am J Gastroenterol"},{"key":"76_CR18","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1136\/gut.34.2.150","volume":"34","author":"A Ferguson","year":"1993","unstructured":"Ferguson A, Arranz E, O\u2019Mahony S: Clinical and pathological spectrum of coeliac disease: active, silent, latent, potential. Gut 1993, 34:150\u2013151.","journal-title":"Gut"},{"key":"76_CR19","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1136\/jcp.2003.013607","volume":"57","author":"F Biagi","year":"2004","unstructured":"Biagi F, Luinetti O, Campanella J, et al.: Intraepithelial lymphocytes in the villous tip: Do they indicate potential coeliac disease? J Clin Pathol 2004, 57:835\u2013839.","journal-title":"J Clin Pathol"},{"key":"76_CR20","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1046\/j.1365-2559.2000.00926.x","volume":"37","author":"Serre N Patey-Mariaud De","year":"2000","unstructured":"Patey-Mariaud De Serre N, Cellier C, Jabri B, et al.: Distinction between coeliac disease and refractory sprue: a simple immunohistochemical method. Histopathology 2000, 37:70\u201377.","journal-title":"Histopathology"},{"key":"76_CR21","doi-asserted-by":"crossref","first-page":"4170","DOI":"10.4049\/jimmunol.166.6.4170","volume":"166","author":"R Marzari","year":"2001","unstructured":"Marzari R, Sblattero D, Florian F, et al.: Molecular dissection of the tissue transglutaminase autoantibody response in celiac disease. J Immunol 2001, 166:4170\u20134176. The possible role of anti-transglutaminase antibodies in the onset of CD and associated autoimmune pathologies is discussed.","journal-title":"J Immunol"},{"key":"76_CR22","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1136\/gut.2003.024836","volume":"53","author":"IR Korponay-Szabo","year":"2004","unstructured":"Korponay-Szabo IR, Halttunen T, Szalai Z, et al.: In vivo targeting of intestinal and extraintestinal transglutaminase 2 by coeliac autoantibodies. Gut 2004, 53:641\u2013648.","journal-title":"Gut"},{"key":"76_CR23","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1080\/00365520510023422","volume":"40","author":"K Kaukinen","year":"2005","unstructured":"Kaukinen K, Peraaho M, Collin P, et al.: Small-bowel mucosal transglutaminase 2-specific IgA deposits in coeliac disease without villous atrophy: a prospective and randomized clinical study. Scand J Gastroenterol 2005, 40:564\u2013572. Clinical CD may occur despite normal small bowel mucosal villous architecture. Mucosal transglutaminase 2-specific IgA deposits can be utilized in detecting such patients.","journal-title":"Scand J Gastroenterol"},{"key":"76_CR24","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1136\/gut.47.4.520","volume":"47","author":"MG Clemente","year":"2000","unstructured":"Clemente MG, Musu MP, Frau F, et al.: Immune reaction against the cytoskeleton in coeliac disease. Gut 2000, 47:520\u2013526.","journal-title":"Gut"},{"key":"76_CR25","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1111\/j.1572-0241.2004.30296.x","volume":"99","author":"MG Clemente","year":"2004","unstructured":"Clemente MG, Musu MP, Troncone R, et al.: Enterocyte actin autoantibody detection: a new diagnostic tool in celiac disease diagnosis: results of a multicenter study. Am J Gastroenterol 2004, 99:1551\u20131556. This multicenter study discusses a new method that could represent a practical tool in the diagnosis of CD when the histologic picture is difficult to interpret.","journal-title":"Am J Gastroenterol"},{"key":"76_CR26","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1371\/journal.pmed.0010001","volume":"1","author":"H Arentz-Hansen","year":"2004","unstructured":"Arentz-Hansen H, Fleckenstein B, Molberg O, et al.: The molecular basis for oat intolerance in patients with celiac disease. PLoS Med 2004, 1:e1.","journal-title":"PLoS Med"},{"key":"76_CR27","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.jada.2004.04.025","volume":"104","author":"M Peraaho","year":"2004","unstructured":"Peraaho M, Collin P, Kaukinen K, et al.: Oats can diversify a gluten-free diet in celiac disease and dermatitis herpetiformis. J Am Diet Assoc 2004, 104:1148\u20131150.","journal-title":"J Am Diet Assoc"},{"key":"76_CR28","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1056\/NEJM200411043511924","volume":"351","author":"T Thompson","year":"2004","unstructured":"Thompson T: Gluten contamination of commercial oat products in the United States. N Engl J Med 2004, 351:2021\u20132022.","journal-title":"N Engl J Med"},{"key":"76_CR29","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1111\/j.1365-2036.2004.01961.x","volume":"19","author":"P Collin","year":"2004","unstructured":"Collin P, Thorell L, Kaukinen K, et al.: The safe threshold for gluten contamination in gluten-free products. Can trace amounts be accepted in the treatment of coeliac disease? Aliment Pharmacol Ther 2004, 19:1277\u20131283. The gluten content was analyzed in gluten-free products on the market. The daily intake of this gluten-free product was calculated, and mucosa histology was analyzed in 76 adults.","journal-title":"Aliment Pharmacol Ther"},{"key":"76_CR30","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1046\/j.1365-2036.2003.01425.x","volume":"17","author":"M Peraaho","year":"2003","unstructured":"Peraaho M, Kaukinen K, Paasikivi K, et al.: Wheat-starch-based gluten-free products in the treatment of newly detected coeliac disease: prospective and randomized study. Aliment Pharmacol Ther 2003, 17:587\u2013594.","journal-title":"Aliment Pharmacol Ther"},{"key":"76_CR31","doi-asserted-by":"crossref","first-page":"S1775","DOI":"10.1053\/j.gastro.2005.02.027","volume":"128","author":"C Catassi","year":"2005","unstructured":"Catassi C, Fabiani E, Iacono Giuseppe, et al.: Toxicity of gluten traces in patients on treatment for celiac disease. Results of a prospective, placebo controlled, double blind randomized study. Gastroenterology 2005, 128:S1775.","journal-title":"Gastroenterology"},{"key":"76_CR32","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1124\/jpet.104.068429","volume":"311","author":"JL Piper","year":"2004","unstructured":"Piper JL, Gray GM, Khosla C: Effect of prolyl endopeptidase on digestive-resistant gliadin peptides in vivo. J Pharmacol Exp Ther 2004, 311:213\u2013219.","journal-title":"J Pharmacol Exp Ther"},{"key":"76_CR33","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1124\/jpet.104.073312","volume":"312","author":"T Marti","year":"2005","unstructured":"Marti T, Molberg O, Li Q, et al.: Prolyl endopeptidase-mediated destruction of T cell epitopes in whole gluten: chemical and immunological characterization. J Pharmacol Exp Ther 2005, 312:19\u201326.","journal-title":"J Pharmacol Exp Ther"},{"key":"76_CR34","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1053\/j.gastro.2005.06.016","volume":"129","author":"T Matysiak-Budnik","year":"2005","unstructured":"Matysiak-Budnik T, Candalh C, Cellier C, et al.: Limited efficiency of prolyl-endopeptidase in the detoxification of gliadin peptides in celiac disease. Gastroenterology 2005, 129:786\u2013796.","journal-title":"Gastroenterology"},{"key":"76_CR35","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1128\/AEM.68.2.623-633.2002","volume":"68","author":"R Cagno Di","year":"2002","unstructured":"Di Cagno R, De Angelis M, Lavermicocca P, et al.: Proteolysis by sourdough lactic acid bacteria: effects on wheat flour protein fractions and gliadin peptides involved in human cereal intolerance. Appl Environ Microbiol 2002, 68:623\u2013633.","journal-title":"Appl Environ Microbiol"},{"key":"76_CR36","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1128\/AEM.70.2.1088-1096.2004","volume":"70","author":"R Cagno Di","year":"2004","unstructured":"Di Cagno R, De Angelis M, Auricchio S, et al.: Sourdough bread made from wheat and nontoxic flours and started with selected lactobacilli is tolerated in celiac sprue patients. Appl Environ Microbiol 2004, 70:1088\u20131096. This study shows that a bread biotechnology that uses selected lactobacilli, nontoxic flours, and a long fermentation time is a novel tool for decreasing the level of gluten intolerance in humans.","journal-title":"Appl Environ Microbiol"},{"key":"76_CR37","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S0167-5699(98)01416-9","volume":"20","author":"M Piacentini","year":"1999","unstructured":"Piacentini M, Colizzi V: Tissue transglutaminase: apoptosis versus autoimmunity. Immunol Today 1999, 20:130\u2013134.","journal-title":"Immunol Today"},{"key":"76_CR38","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S1074-5521(03)00055-3","volume":"10","author":"D Schuppan","year":"2003","unstructured":"Schuppan D, Dieterich W: A molecular warhead and its target: tissue transglutaminase and celiac sprue. Chem Biol 2003, 10:199\u2013201.","journal-title":"Chem Biol"},{"key":"76_CR39","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/00004836-198506000-00009","volume":"7","author":"SO Ukabam","year":"1985","unstructured":"Ukabam SO, Cooper BT: Small intestinal permeability as an indicator of jejunal mucosal recovery in patients with celiac sprue on a gluten-free diet. J Clin Gastroenterol 1985, 7:232\u2013236.","journal-title":"J Clin Gastroenterol"},{"key":"76_CR40","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1016\/S0140-6736(00)02169-3","volume":"355","author":"A Fasano","year":"2000","unstructured":"Fasano A, Not T, Wang W, et al.: Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease. Lancet 2000, 355:1518\u20131519.","journal-title":"Lancet"},{"key":"76_CR41","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1073\/pnas.0500178102","volume":"102","author":"T Watts","year":"2005","unstructured":"Watts T, Berti I, Sapone A, et al.: Role of the intestinal tight junction modulator zonulin in the pathogenesis of type I diabetes in BB diabetic-prone rats. Proc Natl Acad Sci U S A 2005, 102:2916\u20132921. The findings of this study suggest that the zonulin-induced loss in small intestinal barrier function is involved in the pathogenesis of type 1 diabetes in the BB diabetic-prone animal model.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"76_CR42","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1053\/j.gastro.2005.02.027","volume":"128","author":"C Catassi","year":"2005","unstructured":"Catassi C, Bearzi I, Holmes GK: Association of celiac disease and intestinal lymphomas and other cancers. Gastroenterology 2005, 128(4 Suppl 1):S79-S86.","journal-title":"Gastroenterology"},{"key":"76_CR43","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/00005176-200402000-00014","volume":"38","author":"S Kolacek","year":"2004","unstructured":"Kolacek S, Jadresin O, Petkovic I, et al.: Gluten-free diet has a beneficial effect on chromosome instability in lymphocytes of children with coeliac disease. J Pediatr Gastroenterol Nutr 2004, 38:177\u2013180.","journal-title":"J Pediatr Gastroenterol Nutr"}],"container-title":["Current Gastroenterology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-005-0076-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11894-005-0076-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-005-0076-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T00:03:54Z","timestamp":1559433834000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11894-005-0076-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,11]]}},"alternative-id":["76"],"URL":"https:\/\/doi.org\/10.1007\/s11894-005-0076-z","relation":{},"ISSN":["1522-8037","1534-312X"],"issn-type":[{"value":"1522-8037","type":"print"},{"value":"1534-312X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,11]]}}}